282 related articles for article (PubMed ID: 10096551)
1. Walker 256/S carcinosarcoma causes osteoporosis-like changes through ectopical secretion of luteinizing hormone-releasing hormone.
Waki Y; Nomura M; Kasugai S; Ohya K; Miyamoto K
Cancer Res; 1999 Mar; 59(6):1219-24. PubMed ID: 10096551
[TBL] [Abstract][Full Text] [Related]
2. Postmenopause-like bone loss by mammary carcinoma Walker256/S which secretes luteinizing hormone-releasing hormone.
Waki Y; Miyamoto K; Yamamoto S; Saitoh Y; Kasugai S; Ohya K
Jpn J Pharmacol; 1999 Jun; 80(2):119-25. PubMed ID: 10440530
[TBL] [Abstract][Full Text] [Related]
3. Preclinical evaluation of targeted cytotoxic luteinizing hormone-releasing hormone analogue AN-152 in androgen-sensitive and insensitive prostate cancers.
Letsch M; Schally AV; Szepeshazi K; Halmos G; Nagy A
Clin Cancer Res; 2003 Oct; 9(12):4505-13. PubMed ID: 14555524
[TBL] [Abstract][Full Text] [Related]
4. Osteoporosis-like changes in Walker carcinoma 256-bearing rats, not accompanied with hypercalcemia or parathyroid hormone-related protein production.
Waki Y; Miyamoto K; Kasugai S; Ohya K
Jpn J Cancer Res; 1995 May; 86(5):470-6. PubMed ID: 7540609
[TBL] [Abstract][Full Text] [Related]
5. Age-related decrease in hypothalamic gonadotropin-releasing hormone (GnRH) gene expression, but not pituitary responsiveness to GnRH, in the male Brown Norway rat.
Gruenewald DA; Naai MA; Marck BT; Matsumoto AM
J Androl; 2000; 21(1):72-84. PubMed ID: 10670522
[TBL] [Abstract][Full Text] [Related]
6. NTP Toxicology and Carcinogenesis Studies of Salicylazosulfapyridine (CAS No. 599-79-1) in F344/N Rats and B6C3F1 Mice (Gavage Studies).
National Toxicology Program
Natl Toxicol Program Tech Rep Ser; 1997 May; 457():1-327. PubMed ID: 12587019
[TBL] [Abstract][Full Text] [Related]
7. Effective treatment of metastatic MDA-MB-435 human estrogen-independent breast carcinomas with a targeted cytotoxic analogue of luteinizing hormone-releasing hormone AN-207.
Chatzistamou L; Schally AV; Nagy A; Armatis P; Szepeshazi K; Halmos G
Clin Cancer Res; 2000 Oct; 6(10):4158-65. PubMed ID: 11051271
[TBL] [Abstract][Full Text] [Related]
8. Influence of the selective oestrogen receptor modulator (raloxifene hydrochloride) on IL-6, TNF-alpha, TGF-beta1 and bone turnover markers in the treatment of postmenopausal osteoporosis.
Ozmen B; Kirmaz C; Aydin K; Kafesciler SO; Guclu F; Hekimsoy Z
Eur Cytokine Netw; 2007 Sep; 18(3):148-53. PubMed ID: 17823083
[TBL] [Abstract][Full Text] [Related]
9. Skin temperature rise induced by calcitonin gene-related peptide in gonadotropin-releasing hormone analogue-treated female rats and alleviation by Keishi-bukuryo-gan, a Japanese herbal medicine.
Noguchi M; Ikarashi Y; Yuzurihara M; Kase Y; Watanabe K; Plotnikoff GA; Takeda S; Aburada M
Life Sci; 2005 Mar; 76(18):2079-90. PubMed ID: 15826875
[TBL] [Abstract][Full Text] [Related]
10. Bone loss in ovariectomized rats: dominant role for estrogen but apparently not for FSH.
Rouach V; Katzburg S; Koch Y; Stern N; Somjen D
J Cell Biochem; 2011 Jan; 112(1):128-37. PubMed ID: 21053364
[TBL] [Abstract][Full Text] [Related]
11. Effects of salmon gonadotropin-releasing hormone on follicle stimulating hormone secretion and subunit gene expression in coho salmon (Oncorhynchus kisutch).
Dickey JT; Swanson P
Gen Comp Endocrinol; 2000 Jun; 118(3):436-49. PubMed ID: 10843795
[TBL] [Abstract][Full Text] [Related]
12. Growth hormone-releasing hormone and glucocorticoids determine the balance between luteinising hormone (LH) beta- and LH beta/follicle-stimulating hormone beta-positive gonadotrophs and somatotrophs in the 14-day-old rat pituitary tissue in aggregate cell culture.
Pals K; Roudbaraki M; Denef C
J Neuroendocrinol; 2008 May; 20(5):535-48. PubMed ID: 18363807
[TBL] [Abstract][Full Text] [Related]
13. Complete regression of MX-1 human breast carcinoma xenografts after targeted chemotherapy with a cytotoxic analog of luteinizing hormone-releasing hormone, AN-207.
Kahán Z; Nagy A; Schally AV; Halmos G; Arencibia JM; Groot K
Cancer; 1999 Jun; 85(12):2608-15. PubMed ID: 10375109
[TBL] [Abstract][Full Text] [Related]
14. Expression of regucalcin in rat bone marrow cells: involvement of osteoclastic bone resorption in regucalcin transgenic rats.
Yamaguchi M; Sawada N; Uchiyama S; Misawa H; Ma ZJ
Int J Mol Med; 2004 Mar; 13(3):437-43. PubMed ID: 14767576
[TBL] [Abstract][Full Text] [Related]
15. Constitutive in vivo mRNA expression by osteocytes of beta-actin, osteocalcin, connexin-43, IGF-I, c-fos and c-jun, but not TNF-alpha nor tartrate-resistant acid phosphatase.
Mason DJ; Hillam RA; Skerry TM
J Bone Miner Res; 1996 Mar; 11(3):350-7. PubMed ID: 8852945
[TBL] [Abstract][Full Text] [Related]
16. In vitro release of luteinizing hormone releasing hormone (LH-RH) from the hypothalamus in pregnant rats.
Hiratsuka K
Nihon Sanka Fujinka Gakkai Zasshi; 1983 Dec; 35(12):2409-13. PubMed ID: 6363575
[TBL] [Abstract][Full Text] [Related]
17. Low-level lifetime exposure to cadmium decreases skeletal mineralization and enhances bone loss in aged rats.
Brzóska MM; Moniuszko-Jakoniuk J
Bone; 2004 Nov; 35(5):1180-91. PubMed ID: 15542044
[TBL] [Abstract][Full Text] [Related]
18. Evidence for a prospective anti-osteoporosis effect of black tea (Camellia Sinensis) extract in a bilaterally ovariectomized rat model.
Das AS; Mukherjee M; Mitra C
Asia Pac J Clin Nutr; 2004; 13(2):210-6. PubMed ID: 15228990
[TBL] [Abstract][Full Text] [Related]
19. Changes in the serum sex steroids, IL-7 and RANKL-OPG system after bone marrow transplantation: influences on bone and mineral metabolism.
Baek KH; Oh KW; Lee WY; Tae HJ; Rhee EJ; Han JH; Cha BY; Kim YJ; Lee KW; Son HY; Kang SK; Kim CC; Kang MI
Bone; 2006 Dec; 39(6):1352-60. PubMed ID: 16905375
[TBL] [Abstract][Full Text] [Related]
20. NTP Toxicology and Carcinogenesis Studies of C.I. Direct Blue 218 (CAS No. 28407-37-6) in F344/N Rats and B6C3F1 Mice (Feed Studies).
National Toxicology Program
Natl Toxicol Program Tech Rep Ser; 1994 Feb; 430():1-280. PubMed ID: 12616301
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
